Latest Breaking News On - Rocket pharmaceuticals trading down - Page 1 : vimarsana.com

Needham & Company LLC Reaffirms Buy Rating for Rocket Pharmaceuticals (NASDAQ:RCKT)

Needham & Company LLC Reaffirms Buy Rating for Rocket Pharmaceuticals (NASDAQ:RCKT)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Davidp southwellZurcher kantonalbank zurich cantonalbankHedge funds weigh in on rocket pharmaceuticalsCantor fitzgeraldAllspring global investments holdingsMirae asset global investments coNews ratings for rocket pharmaceuticals dailyAnalyst recommendations for rocket pharmaceuticalsTd asset management incJpmorgan chase coRocket pharmaceuticals trading downInsider transactions at rocket pharmaceuticalsRocket pharmaceuticalsNeedham companyGoldman sachs groupRocket pharmaceuticals inc

Rocket Pharmaceuticals (NASDAQ:RCKT) Announces Quarterly Earnings Results

Rocket Pharmaceuticals (NASDAQ:RCKT) Announces Quarterly Earnings Results
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Kinnari patelGaurav shahRocket pharmaceuticals trading downEarnings history for rocket pharmaceuticalsNeedham companySecurities exchange commissionRocket pharmaceuticalsGoldman sachs groupJpmorgan chase coNews ratings for rocket pharmaceuticals dailyRocket pharmaceuticals incGet free reportPharmaceuticals trading downExchange commissionRocket pharmaceuticals daily

Rocket Pharmaceuticals, Inc (NASDAQ:RCKT) Given Average Rating of Moderate Buy by Brokerages

Rocket Pharmaceuticals, Inc (NASDAQ:RCKT) Given Average Rating of Moderate Buy by Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Gaurav shahMartin wilsonNeedham companyRocket pharmaceuticalsWells fargo companySteward partners investment advisoryJpmorgan chase coInsider activity at rocket pharmaceuticalsNews ratings for rocket pharmaceuticals dailyRocket pharmaceuticals trading downChina universal asset management coCantor fitzgeraldRocket pharmaceuticals incAnalyst recommendations for rocket pharmaceuticalsAdvisor group holdings incRocket pharmaceuticals company profile

Rocket Pharmaceuticals (RCKT) Overweight Rating Reaffirmed at Cantor Fitzgerald

Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report)‘s stock had its “overweight” rating restated by investment analysts at Cantor Fitzgerald in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $65.00 target price on the biotechnology company’s stock. Cantor Fitzgerald’s price objective suggests a potential upside of 118.93% from the stock’s […]

Martin wilsonKinnari patelRocket pharmaceuticals incRocket pharmaceuticalsRocket pharmaceuticals trading downNews ratings for rocket pharmaceuticals dailyHedge funds weigh in on rocket pharmaceuticalsMetlife investment managementNeedham companyJpmorgan chase coCantor fitzgeraldInsider transactions at rocket pharmaceuticalsAnalyst recommendations for rocket pharmaceuticalsSynovus financial corpHightower advisorsGet free report

Privium Fund Management B V Has $2 94 Million Stake in Rocket Pharmaceuticals, Inc (NASDAQ:RCKT)

Privium Fund Management B.V. raised its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 141.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 143,350 shares of the biotechnology company’s stock after buying an additional 84,000 shares during the […]

Gotham makkerWells fargo companyPrivium fund managementSecurities exchange commissionCantor fitzgeraldAdvisor group holdings incChina universal asset management coNeedham companyNews ratings for rocket pharmaceuticals dailyRocket pharmaceuticals trading downSteward partners investment advisoryRocket pharmaceuticals incLife insurance coRocket pharmaceuticalsQuarter for rocket pharmaceuticalsFree report